论文信息 - Combined Epidermal Growth Factor Receptor Targeting with the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225) - 字舞流文

Combined Epidermal Growth Factor Receptor Targeting with the Tyrosine Kinase Inhibitor Gefitinib (ZD1839) and the Monoclonal Antibody Cetuximab (IMC-C225)

J. Baselga | F. Rojo | J. Tabernero | J. Arribas | S. Di Cosimo | G. Moreno-Bueno | J. Palacios | R. Cassia | S. Rodríguez | P. Matar | M. Guzman